Table 1. Neoantigen Peptides Manufacturing Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Neoantigen Peptides Manufacturing Market Restraints

Table 3. Neoantigen Peptides Manufacturing Market Trends

Table 4. Neoantigen Peptides Manufacturing Industry Policy

Table 5. Global Neoantigen Peptides Manufacturing Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Neoantigen Peptides Manufacturing Revenue Market Share by Company (2018-2023)

Table 7. Global Neoantigen Peptides Manufacturing Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Neoantigen Peptides Manufacturing Mergers & Acquisitions, Expansion Plans

Table 9. Global Neoantigen Peptides Manufacturing Manufacturers Product Type

Table 10. China Neoantigen Peptides Manufacturing Revenue by Company (2018-2023) & (US$ million)

Table 11. China Neoantigen Peptides Manufacturing Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Neoantigen Peptides Manufacturing Upstream (Raw Materials)

Table 13. Global Neoantigen Peptides Manufacturing Typical Customers

Table 14. Neoantigen Peptides Manufacturing Typical Distributors

Table 15. By Type, Global Neoantigen Peptides Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Neoantigen Peptides Manufacturing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Neoantigen Peptides Manufacturing Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Neoantigen Peptides Manufacturing Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Neoantigen Peptides Manufacturing Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Neoantigen Peptides Manufacturing Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2029

Table 22. Cpc Scientific Inc Company Information, Head Office, Market Area and Industry Position

Table 23. Cpc Scientific Inc Company Profile and Main Business

Table 24. Cpc Scientific Inc Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 25. Cpc Scientific Inc Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 26. Cpc Scientific Inc Recent Developments

Table 27. Polypeptide Group Company Information, Head Office, Market Area and Industry Position

Table 28. Polypeptide Group Company Profile and Main Business

Table 29. Polypeptide Group Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 30. Polypeptide Group Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 31. Polypeptide Group Recent Developments

Table 32. Genscript Biotech Company Information, Head Office, Market Area and Industry Position

Table 33. Genscript Biotech Company Profile and Main Business

Table 34. Genscript Biotech Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 35. Genscript Biotech Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 36. Genscript Biotech Recent Developments

Table 37. Kaneka Eurogentec SA Company Information, Head Office, Market Area and Industry Position

Table 38. Kaneka Eurogentec SA Company Profile and Main Business

Table 39. Kaneka Eurogentec SA Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 40. Kaneka Eurogentec SA Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 41. Kaneka Eurogentec SA Recent Developments

Table 42. Vivitide Company Information, Head Office, Market Area and Industry Position

Table 43. Vivitide Company Profile and Main Business

Table 44. Vivitide Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 45. Vivitide Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 46. Vivitide Recent Developments

Table 47. Almac Company Information, Head Office, Market Area and Industry Position

Table 48. Almac Company Profile and Main Business

Table 49. Almac Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 50. Almac Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 51. Almac Recent Developments

Table 52. Bcn Peptides Company Information, Head Office, Market Area and Industry Position

Table 53. Bcn Peptides Company Profile and Main Business

Table 54. Bcn Peptides Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 55. Bcn Peptides Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 56. Bcn Peptides Recent Developments

Table 57. Creative Peptides Company Information, Head Office, Market Area and Industry Position

Table 58. Creative Peptides Company Profile and Main Business

Table 59. Creative Peptides Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 60. Creative Peptides Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 61. Creative Peptides Recent Developments

Table 62. Pepscan Company Information, Head Office, Market Area and Industry Position

Table 63. Pepscan Company Profile and Main Business

Table 64. Pepscan Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 65. Pepscan Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 66. Pepscan Recent Developments

Table 67. Provepharm Company Information, Head Office, Market Area and Industry Position

Table 68. Provepharm Company Profile and Main Business

Table 69. Provepharm Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 70. Provepharm Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 71. Provepharm Recent Developments

Table 72. Creosalus Company Information, Head Office, Market Area and Industry Position

Table 73. Creosalus Company Profile and Main Business

Table 74. Creosalus Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 75. Creosalus Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 76. Creosalus Recent Developments

Table 77. Gyros Protein Technologies Company Information, Head Office, Market Area and Industry Position

Table 78. Gyros Protein Technologies Company Profile and Main Business

Table 79. Gyros Protein Technologies Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 80. Gyros Protein Technologies Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 81. Gyros Protein Technologies Recent Developments

Table 82. Anaspec Company Information, Head Office, Market Area and Industry Position

Table 83. Anaspec Company Profile and Main Business

Table 84. Anaspec Neoantigen Peptides Manufacturing Models, Specifications and Application

Table 85. Anaspec Neoantigen Peptides Manufacturing Revenue and Gross Margin, 2018-2023

Table 86. Anaspec Recent Developments

List of Figure

Figure 1. Neoantigen Peptides Manufacturing Picture

Figure 2. Global Neoantigen Peptides Manufacturing Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Neoantigen Peptides Manufacturing Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Neoantigen Peptides Manufacturing Market Share of Global

Figure 5. Global Neoantigen Peptides Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Neoantigen Peptides Manufacturing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Neoantigen Peptides Manufacturing Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Neoantigen Peptides Manufacturing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Neoantigen Peptides Manufacturing Industry Chain

Figure 10. Olid Phase Synthesis

Figure 11. Solution Phase Synthesis

Figure 12. By Type, Global Neoantigen Peptides Manufacturing Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2029

Figure 14. Pharmaceutical/Vaccine Developer Companies

Figure 15. Contract Research Organizations (CRO)

Figure 16. Others

Figure 17. By Application, Global Neoantigen Peptides Manufacturing Revenue, 2018-2029, US$ Million

Figure 18. By Application, Global Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2029

Figure 19. By Region, Global Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2029

Figure 20. North America Neoantigen Peptides Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 21. By Country, North America Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2023

Figure 22. Europe Neoantigen Peptides Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, Europe Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2023

Figure 24. Asia Pacific Neoantigen Peptides Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country/Region, Asia Pacific Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2023

Figure 26. South America Neoantigen Peptides Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, South America Neoantigen Peptides Manufacturing Revenue Market Share, 2018-2023

Figure 28. Middle East & Africa Neoantigen Peptides Manufacturing Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. U.S. Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 30. By Company, U.S. Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 31. By Type, U.S. Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 33. Europe Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, Europe Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 35. By Type, Europe Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 36. By Application, Europe Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 37. China Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, China Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 39. By Type, China Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 40. By Application, China Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 41. Japan Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, Japan Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 43. By Type, Japan Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 44. By Application, Japan Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 45. South Korea Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, South Korea Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 47. By Type, South Korea Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 48. By Application, South Korea Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 49. Southeast Asia Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, Southeast Asia Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 51. By Type, Southeast Asia Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 52. By Application, Southeast Asia Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 53. India Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, India Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 55. By Type, India Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 56. By Application, India Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 57. Middle East & Asia Neoantigen Peptides Manufacturing Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, Middle East & Asia Neoantigen Peptides Manufacturing Market Share, 2018-2023

Figure 59. By Type, Middle East & Asia Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 60. By Application, Middle East & Asia Neoantigen Peptides Manufacturing Revenue Market Share, 2022 VS 2029

Figure 61. Research Methodology

Figure 62. Breakdown of Primary Interviews

Figure 63. Bottom-up Approaches

Figure 64. Top-down Approaches